Quoting IQVIA sales data, the company said, Dapagliflozin Tablets, have an estimated market size of USD 1.7 billion for 12 months, ending December 2018.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2YcTx6Q
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Alembic Pharma gets tentative nod from USFDA for glycemic control drug
0 comments:
Post a Comment